Report Detail

Request for Sample of this report

Other Global Oncology Biomarker Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4607399
    • |
  • 13 August, 2024
    • |
  • Global
    • |
  • 110 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Oncology Biomarker market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
A biomarker is referred to as a traceable biomolecule, whose presence found in body fluids such as blood, serum, urine, and tumor fluid that indicates disease or an underlying condition such as cancer.
The Global Info Research report includes an overview of the development of the Oncology Biomarker industry chain, the market status of Diagnostics (Lung Cancer, Breast Cancer), Drug Discovery And Development (Lung Cancer, Breast Cancer), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oncology Biomarker.
Regionally, the report analyzes the Oncology Biomarker markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oncology Biomarker market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Oncology Biomarker market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oncology Biomarker industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Lung Cancer, Breast Cancer).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oncology Biomarker market.
Regional Analysis: The report involves examining the Oncology Biomarker market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oncology Biomarker market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Oncology Biomarker:
Company Analysis: Report covers individual Oncology Biomarker players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oncology Biomarker This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Diagnostics, Drug Discovery And Development).
Technology Analysis: Report covers specific technologies relevant to Oncology Biomarker. It assesses the current state, advancements, and potential future developments in Oncology Biomarker areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oncology Biomarker market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Oncology Biomarker market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Stomach Cancer
Others
Market segment by Application
Diagnostics
Drug Discovery And Development
Prognostics
Risk Assessment
Others
Market segment by players, this report covers
Abbott Laboratories
Bristol-Myers Squibb
Eli Lilly and Company
F.Hoffmann-La Roche Ltd.
Genomic Health
GlaxoSmithKline plc
Novartis AG
Merck & Co.
Pfizer
Qiagen N.V.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oncology Biomarker product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncology Biomarker, with revenue, gross margin and global market share of Oncology Biomarker from 2019 to 2024.
Chapter 3, the Oncology Biomarker competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Oncology Biomarker market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncology Biomarker.
Chapter 13, to describe Oncology Biomarker research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Oncology Biomarker
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Oncology Biomarker by Type
    • 1.3.1 Overview: Global Oncology Biomarker Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Oncology Biomarker Consumption Value Market Share by Type in 2023
    • 1.3.3 Lung Cancer
    • 1.3.4 Breast Cancer
    • 1.3.5 Colorectal Cancer
    • 1.3.6 Prostate Cancer
    • 1.3.7 Stomach Cancer
    • 1.3.8 Others
  • 1.4 Global Oncology Biomarker Market by Application
    • 1.4.1 Overview: Global Oncology Biomarker Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Diagnostics
    • 1.4.3 Drug Discovery And Development
    • 1.4.4 Prognostics
    • 1.4.5 Risk Assessment
    • 1.4.6 Others
  • 1.5 Global Oncology Biomarker Market Size & Forecast
  • 1.6 Global Oncology Biomarker Market Size and Forecast by Region
    • 1.6.1 Global Oncology Biomarker Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Oncology Biomarker Market Size by Region, (2019-2030)
    • 1.6.3 North America Oncology Biomarker Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Oncology Biomarker Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Oncology Biomarker Market Size and Prospect (2019-2030)
    • 1.6.6 South America Oncology Biomarker Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Oncology Biomarker Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Abbott Laboratories
    • 2.1.1 Abbott Laboratories Details
    • 2.1.2 Abbott Laboratories Major Business
    • 2.1.3 Abbott Laboratories Oncology Biomarker Product and Solutions
    • 2.1.4 Abbott Laboratories Oncology Biomarker Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Abbott Laboratories Recent Developments and Future Plans
  • 2.2 Bristol-Myers Squibb
    • 2.2.1 Bristol-Myers Squibb Details
    • 2.2.2 Bristol-Myers Squibb Major Business
    • 2.2.3 Bristol-Myers Squibb Oncology Biomarker Product and Solutions
    • 2.2.4 Bristol-Myers Squibb Oncology Biomarker Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Bristol-Myers Squibb Recent Developments and Future Plans
  • 2.3 Eli Lilly and Company
    • 2.3.1 Eli Lilly and Company Details
    • 2.3.2 Eli Lilly and Company Major Business
    • 2.3.3 Eli Lilly and Company Oncology Biomarker Product and Solutions
    • 2.3.4 Eli Lilly and Company Oncology Biomarker Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Eli Lilly and Company Recent Developments and Future Plans
  • 2.4 F.Hoffmann-La Roche Ltd.
    • 2.4.1 F.Hoffmann-La Roche Ltd. Details
    • 2.4.2 F.Hoffmann-La Roche Ltd. Major Business
    • 2.4.3 F.Hoffmann-La Roche Ltd. Oncology Biomarker Product and Solutions
    • 2.4.4 F.Hoffmann-La Roche Ltd. Oncology Biomarker Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 F.Hoffmann-La Roche Ltd. Recent Developments and Future Plans
  • 2.5 Genomic Health
    • 2.5.1 Genomic Health Details
    • 2.5.2 Genomic Health Major Business
    • 2.5.3 Genomic Health Oncology Biomarker Product and Solutions
    • 2.5.4 Genomic Health Oncology Biomarker Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Genomic Health Recent Developments and Future Plans
  • 2.6 GlaxoSmithKline plc
    • 2.6.1 GlaxoSmithKline plc Details
    • 2.6.2 GlaxoSmithKline plc Major Business
    • 2.6.3 GlaxoSmithKline plc Oncology Biomarker Product and Solutions
    • 2.6.4 GlaxoSmithKline plc Oncology Biomarker Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 GlaxoSmithKline plc Recent Developments and Future Plans
  • 2.7 Novartis AG
    • 2.7.1 Novartis AG Details
    • 2.7.2 Novartis AG Major Business
    • 2.7.3 Novartis AG Oncology Biomarker Product and Solutions
    • 2.7.4 Novartis AG Oncology Biomarker Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Novartis AG Recent Developments and Future Plans
  • 2.8 Merck & Co.
    • 2.8.1 Merck & Co. Details
    • 2.8.2 Merck & Co. Major Business
    • 2.8.3 Merck & Co. Oncology Biomarker Product and Solutions
    • 2.8.4 Merck & Co. Oncology Biomarker Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Merck & Co. Recent Developments and Future Plans
  • 2.9 Pfizer
    • 2.9.1 Pfizer Details
    • 2.9.2 Pfizer Major Business
    • 2.9.3 Pfizer Oncology Biomarker Product and Solutions
    • 2.9.4 Pfizer Oncology Biomarker Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Pfizer Recent Developments and Future Plans
  • 2.10 Qiagen N.V.
    • 2.10.1 Qiagen N.V. Details
    • 2.10.2 Qiagen N.V. Major Business
    • 2.10.3 Qiagen N.V. Oncology Biomarker Product and Solutions
    • 2.10.4 Qiagen N.V. Oncology Biomarker Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Qiagen N.V. Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Oncology Biomarker Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Oncology Biomarker by Company Revenue
    • 3.2.2 Top 3 Oncology Biomarker Players Market Share in 2023
    • 3.2.3 Top 6 Oncology Biomarker Players Market Share in 2023
  • 3.3 Oncology Biomarker Market: Overall Company Footprint Analysis
    • 3.3.1 Oncology Biomarker Market: Region Footprint
    • 3.3.2 Oncology Biomarker Market: Company Product Type Footprint
    • 3.3.3 Oncology Biomarker Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Oncology Biomarker Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Oncology Biomarker Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Oncology Biomarker Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Oncology Biomarker Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Oncology Biomarker Consumption Value by Type (2019-2030)
  • 6.2 North America Oncology Biomarker Consumption Value by Application (2019-2030)
  • 6.3 North America Oncology Biomarker Market Size by Country
    • 6.3.1 North America Oncology Biomarker Consumption Value by Country (2019-2030)
    • 6.3.2 United States Oncology Biomarker Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Oncology Biomarker Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Oncology Biomarker Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Oncology Biomarker Consumption Value by Type (2019-2030)
  • 7.2 Europe Oncology Biomarker Consumption Value by Application (2019-2030)
  • 7.3 Europe Oncology Biomarker Market Size by Country
    • 7.3.1 Europe Oncology Biomarker Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Oncology Biomarker Market Size and Forecast (2019-2030)
    • 7.3.3 France Oncology Biomarker Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Oncology Biomarker Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Oncology Biomarker Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Oncology Biomarker Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Oncology Biomarker Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Oncology Biomarker Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Oncology Biomarker Market Size by Region
    • 8.3.1 Asia-Pacific Oncology Biomarker Consumption Value by Region (2019-2030)
    • 8.3.2 China Oncology Biomarker Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Oncology Biomarker Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Oncology Biomarker Market Size and Forecast (2019-2030)
    • 8.3.5 India Oncology Biomarker Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Oncology Biomarker Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Oncology Biomarker Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Oncology Biomarker Consumption Value by Type (2019-2030)
  • 9.2 South America Oncology Biomarker Consumption Value by Application (2019-2030)
  • 9.3 South America Oncology Biomarker Market Size by Country
    • 9.3.1 South America Oncology Biomarker Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Oncology Biomarker Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Oncology Biomarker Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Oncology Biomarker Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Oncology Biomarker Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Oncology Biomarker Market Size by Country
    • 10.3.1 Middle East & Africa Oncology Biomarker Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Oncology Biomarker Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Oncology Biomarker Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Oncology Biomarker Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Oncology Biomarker Market Drivers
  • 11.2 Oncology Biomarker Market Restraints
  • 11.3 Oncology Biomarker Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Oncology Biomarker Industry Chain
  • 12.2 Oncology Biomarker Upstream Analysis
  • 12.3 Oncology Biomarker Midstream Analysis
  • 12.4 Oncology Biomarker Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Oncology Biomarker. Industry analysis & Market Report on Oncology Biomarker is a syndicated market report, published as Global Oncology Biomarker Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Oncology Biomarker market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,641.32
    		3,961.98
    		5,282.64
    		3,128.52
    		4,692.78
    		6,257.04
    		492,802.80
    		739,204.20
    		985,605.60
    		291,728.40
    		437,592.60
    		583,456.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo